Trial to Determine the Efficacy and Safety of JCAR017 in Adult Participants With Aggressive B-Cell Non-Hodgkin Lymphoma

NCT03484702 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
113
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Celgene